Axon Enterprise stock overview

Axon Enterprise (AXON) stock has drawn fresh attention after recent trading, with shares last closing at US$441.73. The company provides public safety technology solutions across software and connected devices for governments and commercial customers.

Short term momentum has cooled, with a 1 day share price return of 1.0% down, a 7 day return of 9.13% down, and a 30 day share price return of 17.23% up, which contrasts with a year to date decline of 21.60% and a 1 year total shareholder return of 43.41% down.

If Axon Enterprise has you looking more broadly at public safety and automation, this could be a good moment to scan 33 robotics and automation stocks

With Axon Enterprise still showing long term gains but a sharp 1 year decline and a value score of 1 suggesting rich pricing, the key question is whether shares are now undervalued or whether the market is already pricing in future growth.

Most Popular Narrative: 27.2% Undervalued

Axon Enterprise's narrative fair value of $606.83 sits well above the recent close at $441.73. This puts a spotlight on how the story behind the stock differs from the current market price.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

The narrative from AryaWinningSon leans heavily on Axon's shift toward recurring software and data revenue, its role in public safety infrastructure, and the long term platform economics that underpin the $606.83 fair value estimate, without revealing the detailed growth, margin, or discount rate assumptions behind it.

Result: Fair Value of $606.83 (UNDERVALUED)

However, this story can be challenged if public budgets tighten and slow contracts, or if competitors match Axon’s software and data offerings and pressure its pricing power.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another view: pricing versus fair ratio

While the narrative fair value of $606.83 points to upside, Axon Enterprise's P/S ratio of 11.9x is rich compared with the US Aerospace & Defense industry at 5.6x and peer average of 7.1x, even though it sits below the 15.4x fair ratio the market could move toward. Is the premium a justified quality mark or a valuation risk if sentiment cools?

For a closer look at how this pricing gap plays out in practice, it is worth checking the valuation breakdown, including how Axon compares with peers across key ratios, through the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals on valuation and sentiment throughout this article, it makes sense to move quickly, review the data, and decide where you stand. To weigh both sides and judge whether the potential upside justifies the concerns, take a closer look at the 1 key reward and 3 important warning signs

Looking for more investment ideas?

If Axon Enterprise sits on your watchlist, do not stop there. Broaden your opportunity set and let data driven filters surface stocks you might otherwise overlook.

• Target higher quality at lower prices by scanning the 44 high quality undervalued stocks to see which stocks the numbers suggest could offer more for every dollar you pay.
• Seek resilience first by focusing on companies highlighted in the 70 resilient stocks with low risk scores, where business stability and lower risk scores are front and center.
• Hunt for underfollowed potential by checking the screener containing 20 high quality undiscovered gems before others pay attention and pricing adjusts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.